Exchange: NASDAQ·Updated 04:15 PM EST
UTHR logo

UTHR United Therapeutics Corp

$577.34
$6.76
(1.16%)
Today
Closed $577.34
$0.00
(0.00%)
After Hours
Reported EarningsNov 4
Mkt Cap$24.88B
Vol416,371.00

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
34

Bearish Sentiment

How do you feel about UTHR?

StocktwitsEarnings
$UTHR Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $5.71 down -20.25% YoY • Reported revenue of $832.5M up 4.13% YoY
1
GweiGamma
$UTHR quietly grinding higher while biotech sentiment keeps improving. Pulmonary hypertension space getting more attention as pipeline plays mature across the sector. Specialty pharma names like this tend to benefit when risk appetite comes back. Long term setup looks solid here.
shoc24
$UTHR reported earnings before the open today. GAAP EPS missed estimates: $5.71 vs. $6.01 expected, according to Stock Meadow.

Advertisement|Remove ads.